Healthcare provider profile · identity verified

Sharon A. Sax

Internal Medicine · CINCINNATI, OH · NPI 1356397608

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	317	129
Levothyroxine Sodium	Levothyroxine Sodium	226	77
Rosuvastatin Calcium	Rosuvastatin Calcium	226	79
Amlodipine Besylate	Amlodipine Besylate	204	78
Metoprolol Succinate	Metoprolol Succinate	160	61
Pantoprazole Sodium	Pantoprazole Sodium	142	55
Lisinopril	Lisinopril	136	49
Omeprazole	Omeprazole	133	56
Metformin Hcl Er	Metformin Hcl	132	51
Gabapentin	Gabapentin	101	39
Eliquis	Apixaban	92	23
Trazodone Hcl	Trazodone Hcl	90	34
Escitalopram Oxalate	Escitalopram Oxalate	83	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	36
Alendronate Sodium	Alendronate Sodium	77	34
Duloxetine Hcl	Duloxetine Hcl	65	23
Hydrochlorothiazide	Hydrochlorothiazide	64	26
Metoprolol Tartrate	Metoprolol Tartrate	63	24
Albuterol Sulfate Hfa	Albuterol Sulfate	61	28
Furosemide	Furosemide	61	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	19
Simvastatin	Simvastatin	61	29
Montelukast Sodium	Montelukast Sodium	60	22
Spironolactone	Spironolactone	59	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	58	21
Tamsulosin Hcl	Tamsulosin Hcl	57	21
Jardiance	Empagliflozin	54	13
Venlafaxine Hcl Er	Venlafaxine Hcl	54	19
Alprazolam	Alprazolam	53	13
Losartan Potassium	Losartan Potassium	53	18
Metformin Hcl	Metformin Hcl	53	21
Meloxicam	Meloxicam	50	16
Ozempic	Semaglutide	46	suppressed
Trulicity	Dulaglutide	46	17
Buspirone Hcl	Buspirone Hcl	45	13
Fluticasone Propionate	Fluticasone Propionate	41	18
Potassium Chloride	Potassium Chloride	40	19
Donepezil Hcl	Donepezil Hcl	38	15
Glimepiride	Glimepiride	38	14
Famotidine	Famotidine	36	21
Nifedipine Er	Nifedipine	36	14
Atenolol	Atenolol	35	15
Bupropion Xl	Bupropion Hcl	35	suppressed
Mirtazapine	Mirtazapine	34	12
Clonazepam	Clonazepam	33	11
Irbesartan	Irbesartan	33	13
Allopurinol	Allopurinol	32	15
Prednisone	Prednisone	32	21
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Torsemide	Torsemide	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Carvedilol	Carvedilol	27	11
Lorazepam	Lorazepam	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Sertraline Hcl	Sertraline Hcl	25	11
Zolpidem Tartrate	Zolpidem Tartrate	25	11
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Azithromycin	Azithromycin	21	20
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Nadolol	Nadolol	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Linzess	Linaclotide	17	suppressed
Repatha Syringe	Evolocumab	17	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Megestrol Acetate	Megestrol Acetate	16	suppressed
Valsartan	Valsartan	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Dilt-Xr	Diltiazem Hcl	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Methylprednisolone	Methylprednisolone	14	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Glipizide	Glipizide	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Quinine Sulfate	Quinine Sulfate	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Topiramate	Topiramate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error